Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Koomen

Showing results (171-180 of 229) with videos related to

Pageof 23
Sort By:
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Proteomics. Clinical Applications|April 12, 2014
Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsElizabeth R Remily-Wood, Kaaron Benson, Rachid C Baz, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Cancer Research|February 12, 2022
Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic AnergyMario R Fernandez, Franz X Schaub, Chunying Yang, et al.
Science Signaling|February 14, 2019
An immunoproteomic approach to characterize the CAR interactome and signalosomeMaria C Ramello, Ismahène Benzaïd, Brent M Kuenzi, et al.
Molecular & Cellular Proteomics : MCP|July 31, 2008
Proteomic contributions to personalized cancer careJohn M Koomen, Eric B Haura, Gerold Bepler, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2025
Reproducible Sectioning and Sample Preparation for Mass Spectrometry Imaging of Cancer Metabolism in Frozen Lung TissueVanessa Y Rubio, Hayley D Ackerman, Nicole Hackel, et al.
Nature Communications|July 4, 2024
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasisSurbhi Chouhan, Dhivya Sridaran, Cody Weimholt, et al.
Pageof 23

Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Proteomics. Clinical Applications|April 12, 2014
Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsElizabeth R Remily-Wood, Kaaron Benson, Rachid C Baz, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
Cancer Research|February 12, 2022
Disrupting the MYC-TFEB Circuit Impairs Amino Acid Homeostasis and Provokes Metabolic AnergyMario R Fernandez, Franz X Schaub, Chunying Yang, et al.
Science Signaling|February 14, 2019
An immunoproteomic approach to characterize the CAR interactome and signalosomeMaria C Ramello, Ismahène Benzaïd, Brent M Kuenzi, et al.
Molecular & Cellular Proteomics : MCP|July 31, 2008
Proteomic contributions to personalized cancer careJohn M Koomen, Eric B Haura, Gerold Bepler, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2025
Reproducible Sectioning and Sample Preparation for Mass Spectrometry Imaging of Cancer Metabolism in Frozen Lung TissueVanessa Y Rubio, Hayley D Ackerman, Nicole Hackel, et al.
Nature Communications|July 4, 2024
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasisSurbhi Chouhan, Dhivya Sridaran, Cody Weimholt, et al.
Pageof 23